FDA issues new warning on liver disease drug
FDA is adding a Boxed Warning, its most prominent warning, on a liver disease medicine.
Read More
Why healthcare organizations will invest more in tech this year
Four essential players for your healthcare data analytics team
Putting together the right team of data specialists is an important part of the future growth of a healthcare organization. Do you have the right team in place?
Four barriers to value-based care
Study reveals growing acceptance of value-based payments among family physicians, but barriers still exist.
Is end-of-life care the place for big data?
The benefits and drawbacks of predictive modeling in end-of-life care decision making.
Five healthcare technologies likely to be developed in the next 10 years
In the next decade, many of the concepts aiming to streamline the healthcare industry could be reality.
How telemedicine will change care delivery and costs in 2018
Health systems realize that telehealth can help them achieve a wide range of objectives, from care coordination to readmission avoidance and market share expansion.
Some Consumers Set to Receive Complimentary Cancer Genomic Profiling
Shift represents growing understanding of value of genetic testing for cancers. Find out who is receiving the test and why.
Amazon, JPMorgan, Berkshire Hathaway collaboration puts insurers ‘on notice’
Corporate giants Amazon, Berkshire Hathaway, and JPMorgan Chase, partner to shake things up in U.S. employee healthcare.
Radioactive drug for digestive cancer snags FDA approval
FDA approved a new drug to treat a type of cancer that affects the pancreas or gastrointestinal tract.
Seven Ways to Help Patients Access Costly Cancer Drugs
Two new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.
Cannabis-derived epilepsy drug on the horizon
A pharmaceutical formulation of purified cannabidiol, a cannabinoid without euphoric side effects, is expected to launch in the second half of this year.
Expert Predicts Outlook for Medicare Advantage, Managed Medicaid
A KPMG-Leavitt Partners report shows Medicare Advantage and Managed Medicaid are on slightly different trajectories. Expert Ash Shehata shares his predictions for both markets.
Top Considerations in Pediatric Cancer Treatment: What Payers Should Know
A Stanford expert describes ideal treatment locations, common barriers, and how payers could better support patients and families.
Cancer Vaccine to Prevent Breast, Ovarian Cancer Recurrence Could be Close
In partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.
Healthcare Data Breaches: 4 Tips for Healthcare Execs
A University of Phoenix College of Health Professions survey has surprising findings about RNs and health administrator views on healthcare hacking.
Four Best Practices to Help Prevent Healthcare Cyberattacks
A new report from Radware has shocking findings about the healthcare industry’s low preparedness levels for cyberthreats. Here’s 4 ways to get ready.
All Healthcare is not Local The Human Cost of Disparate Health Data
How a customized COPD care bundle is reducing readmissions
Reducing readmissions for chronic obstructive pulmonary disease (COPD) is an ongoing challenge for healthcare systems. Here’s how one is successful.
How the Flu’s Severity Will Affect Healthcare Spending
The flu epidemic is taking a toll on the U.S. healthcare system. Here's how health insurers can curtail spending on flu care.
Pfizer VP Robert Popovian Talks Value-Based Reimbursement
The impact of VBRs on outcomes, VBRs versus other healthcare reimbursement initiatives, and VBR successes and failures. Pfizer’s Robert Popovian, PharmD, weighs in.
Blindness gene therapy price tag stirs controversy
A patient advocacy group is criticizing the hefty price tag of a new treatment for blindness.
Four pain management programs curbing the opioid epidemic
From State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.
Expert Predictions: Generic Drug Costs, Biosimilar Impact, Policy Changes
How are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.
Survey uncovers lupus corticosteroid treatment issues
Patients with systemic lupus erythematosus often self-manage their corticosteroid medication without the consent of their healthcare providers, according to a recent multicountry survey.
Five factors driving up the cost of oncology drugs
The high cost of specialty drugs continues to plague the healthcare industry. Here’s why.
Four reasons COPD patients don’t receive the right treatments
Many providers are overlooking important steps that can help guide proper COPD treatment and therefore, reduce admissions and readmissions.
Six things to know about CMS' new bundled payment model
CMS unveiled a voluntary episode bundled payment model, Bundled Payments for Care Improvement Advanced (BPCI Advanced). Here’s six things experts want you to know
Despite hype, private payers slow to adopt oncology value-based models
Oncology Institute’s Dawn Holcombe, MBA, FACMPE, ACHE, shares her views on the OCM program, what CAR T-cell therapy means for the future of reimbursement, and some epic predictions.
Four things to know about your millennial workforce
How actively engaging millennials can help manage healthcare staffing challenges.
